Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
13.48
+2.97 (28.26%)
At close: Jan 21, 2025, 4:00 PM
13.94
+0.46 (3.41%)
After-hours: Jan 21, 2025, 6:42 PM EST
Evolus Employees
Evolus had 273 employees as of December 31, 2023. The number of employees increased by 58 or 26.98% compared to the previous year.
Employees
273
Change (1Y)
58
Growth (1Y)
26.98%
Revenue / Employee
$909,619
Profits / Employee
-$203,150
Market Cap
853.57M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
EOLS News
- 15 hours ago - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company's Guidance - Business Wire
- 4 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 days ago - Evolus: Still Bullish, But Business Faces Tricky Challenges In '25 - Seeking Alpha
- 2 months ago - Evolus, Inc. (EOLS) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - Evolus Reports Third Quarter 2024 Results - Business Wire
- 2 months ago - Evolus to Participate in Stifel 2024 Healthcare Conference - Business Wire
- 2 months ago - Evolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device Regulation - Business Wire
- 3 months ago - Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers - Business Wire